Veröffentlichungen
- BSAVA Kongress 2023
Manchester
23. bis 25. März 2023
- 10. Riemser Diagnostiktage
Greifswald + digital
24. bis 25. November 2022
- DVG Vet Congress
Berlin + digital
13. bis 15. Oktober 2022
Teilnahme am DGK-DVG – Deutsche Gesellschaft für Kleintiermedizin
- Jahrestagung der DVG-Fachgruppe AVID mit Schwerpunkt Bakteriologie
Kloster Banz + digital
14. bis 16. September 2022
Bücher
- Forest Rohwer, Merry Youle, Heather Maughan, and Nao Hisakawa (2014). Life in our phage world: a centennial field guide to the Earth’s most diverse inhabitants. https://coralandphage.org/files/Life_In_Our_Phage_World_sampler.pdf
- Mölling, K. (2020). Kampf den Keimen: Mit Viren aus der Antibiotika-Krise? München: Verlag Dr. Friedrich Pfeil. https://www.amazon.de/Kampf-den-Keimen-Viren-Antibiotika-Krise/dp/3899372654
Artikel
- Pyzik, E., Radzki, R. P., and Urban-Chmiel, R. (2021). Experimental Phage Therapies in Companion Animals with A Historical Review. Bentham Science Publishers. https://pubmed.ncbi.nlm.nih.gov/32223736/
- Loponte, R., Pagnini, U., Iovane, G., and Pisanelli, G. (2021). Phage Therapy in Veterinary Medicine. Antibiotics (Basel) 10. doi: 10.3390/antibiotics10040421. https://pubmed.ncbi.nlm.nih.gov/33920369/
- Squires, R. A. (2021). Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists. Veterinary Dermatology 32, 587. doi: 10.1111/vde.12958. https://pubmed.ncbi.nlm.nih.gov/33870572/
- Ly-Chatain, M. H. (2014). The factors affecting effectiveness of treatment in phages therapy. Front. Microbiol. 5, 51. doi: 10.3389/fmicb.2014.00051. https://pubmed.ncbi.nlm.nih.gov/24600439/
- Moelling, K. (2020). Phages Needed against Resistant Bacteria. Viruses 12, 743. doi: 10.3390/v12070743. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412541/
- Verbeken, G., and Pirnay, J.-P. (2022). European regulatory aspects of phage therapy: magistral phage preparations. Curr Opin Virol 52, 24–29. doi: 10.1016/j.coviro.2021.11.005. https://pubmed.ncbi.nlm.nih.gov/34801778/
- Zagaliotis, P., Michalik-Provasek, J., Gill, J. J., and Walsh, T. J. (2022). Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans. Pathog Immun 7, 1–45. doi: 10.20411/pai.v7i2.516. https://pubmed.ncbi.nlm.nih.gov/36320594/
- LabLoeffler FLI Nr. 25 – kommt aber erst raus.
-
Chanishvili, N., Myelnikov, D., and Blauvelt, T. K. (2022). Professor Giorgi Eliava and the Eliava Institute of Bacteriophage. Phage (New Rochelle) 3, 71–80. doi: 10.1089/phage.2022.0016
-
E. H. Hankin (1895). Observations on Cholera in India. Ind Med Gaz.
-
Eaton, M. D., and Bayne-Jones, S. (1934). Bacteriophage Therapy. JAMA 103, 1769. doi: 10.1001/jama.1934.72750490003007
-
Felix d’Herelle (1917). On an invisible microbe antagonistic to dysentery bacilli.
-
Florian Georg Leupold (2018). Die Geschichte des VEB Serum-Werk Bernburg von 1954 bis 1990 unter besonderer Berücksichtgung biogener Arzneistoffe.
-
Frederick W. Twort (1915). An investigation on the nature of ultra-microscopic viruses.
-
Hankin, E. H. (1905). On the Epidemiology of Plague. J. Hyg. 5, 48–83. doi: 10.1017/s0022172400002357
-
Krueger, A. P., and Scribner E. Jane (1941). The Bacteriophage. JAMA 116, 2269. doi: 10.1001/jama.1941.62820200013011
-
Ruska, H. (1942). “Morphologische Befunde bei der bakteriophagen Lyse,” in Morphologische Befunde bei der bakteriophagen Lyse (Springer, Berlin, Heidelberg), 345–387.
- Forest Rohwer, Merry Youle, Heather Maughan, and Nao Hisakawa (2014). Life in our phage world: a centennial field guide to the Earth’s most diverse inhabitants. https://coralandphage.org/files/Life_In_Our_Phage_World_sampler.pdf
- Mölling, K. (2020). Kampf den Keimen: Mit Viren aus der Antibiotika-Krise? München: Verlag Dr. Friedrich Pfeil. https://www.amazon.de/Kampf-den-Keimen-Viren-Antibiotika-Krise/dp/3899372654
- Pyzik, E., Radzki, R. P., and Urban-Chmiel, R. (2021). Experimental Phage Therapies in Companion Animals with A Historical Review. Bentham Science Publishers. https://pubmed.ncbi.nlm.nih.gov/32223736/
- Loponte, R., Pagnini, U., Iovane, G., and Pisanelli, G. (2021). Phage Therapy in Veterinary Medicine. Antibiotics (Basel) 10. doi: 10.3390/antibiotics10040421. https://pubmed.ncbi.nlm.nih.gov/33920369/
- Squires, R. A. (2021). Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists. Veterinary Dermatology 32, 587. doi: 10.1111/vde.12958. https://pubmed.ncbi.nlm.nih.gov/33870572/
- Ly-Chatain, M. H. (2014). The factors affecting effectiveness of treatment in phages therapy. Front. Microbiol. 5, 51. doi: 10.3389/fmicb.2014.00051. https://pubmed.ncbi.nlm.nih.gov/24600439/
- Moelling, K. (2020). Phages Needed against Resistant Bacteria. Viruses 12, 743. doi: 10.3390/v12070743. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412541/
- Verbeken, G., and Pirnay, J.-P. (2022). European regulatory aspects of phage therapy: magistral phage preparations. Curr Opin Virol 52, 24–29. doi: 10.1016/j.coviro.2021.11.005. https://pubmed.ncbi.nlm.nih.gov/34801778/